Therapy (HCV)
Companies Will Co-Develop Hepatitis C Drugs
Published in Hepatitis Weekly, September 18th, 2000
The deal combines Hybrigenics' functional proteomics and bioinformatics drug discovery integrated platform, with XTL's proprietary in vitro and in vivo predictive models of human HCV.
Hybrigenics will select several potential drug targets using the PIMRider technology to define the specific protein domains involved in protein-protein interactions. XTL will biovalidate these targets and corresponding therapeutics for efficacy in treating HCV using its proprietary cell-based assays and Trimera (XTL) mouse model of HCV...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2000-09-18)
More Articles from Hepatitis Weekly
- Risk Factors
Lack of Apoptosis Inhibitor Might be Cause of Alcohol-Induced Cell Death in HCV+ - Cardiomyopathy
Preserved Hearts Reveal Presence of Hepatitis C in Myocardium - Disease Associations
Study Correlates Pancreatic Dysfunction with Hepatitis C Infection - Hepatitis C Virus
Strategies Investigated to Combat HCV - Histology
Liver Biopsies Useful for Determining if Genotypic Analysis Should be Performed - TT Virus
Coinfection with Hepatitis C Does Not Worsen Liver Conditions - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
